Logo image of CBUS

CIBUS INC (CBUS) Stock Price, Quote, News and Overview

NASDAQ:CBUS - Nasdaq - US17166A1016 - Common Stock - Currency: USD

1.88  -0.17 (-8.29%)

CBUS Quote, Performance and Key Statistics

CIBUS INC

NASDAQ:CBUS (3/3/2025, 8:17:34 PM)

1.88

-0.17 (-8.29%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High23.18
52 Week Low1.8
Market Cap63.69M
Shares33.88M
Float23.01M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)03-20 2025-03-20/amc
IPO07-20 2017-07-20


CBUS short term performance overview.The bars show the price performance of CBUS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40 -50

CBUS long term performance overview.The bars show the price performance of CBUS in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of CBUS is 1.88 USD. In the past month the price decreased by -24.5%. In the past year, price decreased by -90.48%.

CIBUS INC / CBUS Daily stock chart

CBUS Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 20.9 373.71B
AMGN AMGEN INC 15.68 166.89B
GILD GILEAD SCIENCES INC 25.16 144.52B
VRTX VERTEX PHARMACEUTICALS INC 1666.59 124.16B
REGN REGENERON PHARMACEUTICALS 15.01 74.87B
ARGX ARGENX SE - ADR 241.32 37.83B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 31.41B
BNTX BIONTECH SE-ADR N/A 26.75B
ONC BEIGENE LTD-ADR N/A 26.20B
BIIB BIOGEN INC 8.6 20.65B
NTRA NATERA INC N/A 18.89B
GMAB GENMAB A/S -SP ADR 24.69 14.59B

About CBUS

Company Profile

CBUS logo image Cibus, Inc. engages in the research and development of plant traits to seed companies for royalties. The company is headquartered in San Diego, California and currently employs 183 full-time employees. The company went IPO on 2017-07-20. Its business is the development of plant traits that help address specific productivity or yield challenges in farming, such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate. The company is also engaged in developing, certain alternative plant-based oils or bio-based fermentation products. Its technology is its gene editing platform called the Rapid Trait Development System (RTDS). The company is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. The company has a pipeline of five productivity traits, four of which are applicable to multiple crops. These traits are PSR in Canola and HT1 and HT3 in rice. In addition, it also has two advanced traits for Sclerotinia resistance and another novel broadleaf HT trait, HT2.

Company Info

CIBUS INC

6455 Nancy Ridge Drive

San Diego CALIFORNIA US

Employees: 183

Company Website: https://www.cibus.com/

Investor Relations: https://ir.calyxt.com/

Phone: 18584500008

CIBUS INC / CBUS FAQ

What is the stock price of CIBUS INC today?

The current stock price of CBUS is 1.88 USD. The price decreased by -8.29% in the last trading session.


What is the ticker symbol for CIBUS INC stock?

The exchange symbol of CIBUS INC is CBUS and it is listed on the Nasdaq exchange.


On which exchange is CBUS stock listed?

CBUS stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for CIBUS INC stock?

10 analysts have analysed CBUS and the average price target is 17.98 USD. This implies a price increase of 856.25% is expected in the next year compared to the current price of 1.88. Check the CIBUS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is CIBUS INC worth?

CIBUS INC (CBUS) has a market capitalization of 63.69M USD. This makes CBUS a Micro Cap stock.


How many employees does CIBUS INC have?

CIBUS INC (CBUS) currently has 183 employees.


What are the support and resistance levels for CIBUS INC (CBUS) stock?

CIBUS INC (CBUS) has a resistance level at 1.94. Check the full technical report for a detailed analysis of CBUS support and resistance levels.


Is CIBUS INC (CBUS) expected to grow?

The Revenue of CIBUS INC (CBUS) is expected to grow by 267.86% in the next year. Check the estimates tab for more information on the CBUS EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy CIBUS INC (CBUS) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does CIBUS INC (CBUS) stock pay dividends?

CBUS does not pay a dividend.


When does CIBUS INC (CBUS) report earnings?

CIBUS INC (CBUS) will report earnings on 2025-03-20, after the market close.


What is the Price/Earnings (PE) ratio of CIBUS INC (CBUS)?

CIBUS INC (CBUS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-14.79).


What is the Short Interest ratio of CIBUS INC (CBUS) stock?

The outstanding short interest for CIBUS INC (CBUS) is 9.19% of its float. Check the ownership tab for more information on the CBUS short interest.


CBUS Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

CBUS Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to CBUS. Both the profitability and financial health of CBUS have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CBUS Financial Highlights

Over the last trailing twelve months CBUS reported a non-GAAP Earnings per Share(EPS) of -14.79. The EPS decreased by -12.99% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -121.07%
ROE -411.87%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%103.77%
Sales Q2Q%250.95%
EPS 1Y (TTM)-12.99%
Revenue 1Y (TTM)446.45%

CBUS Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 80% to CBUS. The Buy consensus is the average rating of analysts ratings from 10 analysts.

For the next year, analysts expect an EPS growth of 60.45% and a revenue growth 267.86% for CBUS


Ownership
Inst Owners30.15%
Ins Owners18.88%
Short Float %9.19%
Short Ratio12.26
Analysts
Analysts80
Price Target17.98 (856.38%)
EPS Next Y60.45%
Revenue Next Year267.86%